Therapeutic Associations Comprising Anti-PD-1/PD-L1 in Breast Cancer: Clinical Challenges and Perspectives

Therapeutic Associations Comprising Anti-PD-1/PD-L1 in Breast Cancer: Clinical Challenges and Perspectives

Despite a few cases of long-responder patients, immunotherapy with anti-PD-(L)1 has so far proved rather disappointing in monotherapy in metastatic breast cancer, prompting the use of synergistic therapeutic combinations incorporating immunotherapy by immune-checkpoint inhibitors. In addition, a bet...

Full description

Bibliographic Details
Main Authors: Fanny Ledys, Laura Kalfeist, Loick Galland, Emeric Limagne, Sylvain Ladoire
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cancers
Subjects:
breast cancer
PD-1/PD-L1 blockade
immune response
chemotherapies
kinase inhibitors
targeted therapies
Online Access:https://www.mdpi.com/2072-6694/13/23/5999

Internet

https://www.mdpi.com/2072-6694/13/23/5999

Similar Items